Effects of Sepsis on Immune Response, Microbiome and Oxidative Metabolism in Preterm Infants

Anna Parra-Llorca1,2, Alejandro Pinilla-Gonzlez1,2, Laura Torrejón-Rodríguez1,2

  • 1Division of Neonatology, University and Polytechnic Hospital La Fe (HULAFE), 46026 Valencia, Spain.

Insights

This review explores bacterial sepsis in preterm infants, focusing on immune responses, oxidative stress, and their link to microbiota changes. Understanding these mechanisms can aid in early biomarker development for this critical neonatal condition.

Area of Science:

  • Neonatal immunology
  • Microbiology
  • Critical care medicine

Background:

  • Bacterial sepsis presents a significant threat to preterm infants, characterized by high incidence, morbidity, and mortality.
  • The complex interplay of host defense mechanisms and pathogen factors contributes to sepsis pathogenesis in this vulnerable population.

Purpose of the Study:

  • To review the intricate mechanisms underlying bacterial sepsis in preterm neonates.
  • To elucidate the role of the innate immune response and oxidative stress in sepsis development.
  • To explore the potential of these mechanisms as early diagnostic biomarkers and their impact on neonatal gut microbiota.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of the innate immune system's function in neonatal sepsis.
  • Examination of oxidative stress markers and their correlation with sepsis.
  • Assessment of sepsis-induced alterations in neonatal microbiota and dysbiosis.

Main Results:

  • The innate immune system plays a critical role in sepsis pathogenesis, often exacerbated by oxidative stress.
  • Specific immune markers and oxidative stress indicators show potential for early sepsis detection in preterm infants.
  • Sepsis significantly disrupts the developing neonatal microbiota, leading to dysbiosis with potential long-term consequences.

Conclusions:

  • Bacterial sepsis in preterm infants involves a complex interplay of innate immunity and oxidative stress.
  • Early identification of sepsis biomarkers is crucial for improving outcomes.
  • Understanding sepsis-induced microbiota dysbiosis is essential for developing targeted interventions.